Crona Corp.
Crona Corp. is a U.S.-based service company focused on disinfection and anti-microbial protection under its ZeroBlast process. It sells infection-control treatments that are applied to facilities and vehicles to reduce germs, viruses, and pathogens for up to 90 days per treatment cycle.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaHands-on cleaning, disinfection, and anti-microbial protection services for facilities and vehicles.
Pre-treatment contamination testing used to demonstrate infection risk and support service sales.
Scheduled 90-day follow-up treatments that maintain protection and create repeat service revenue.
Asiakkaat
Crona sells infection-control services to organizations that need visible hygiene and pathogen-reduction measures in occupied spaces. Its customer base spans commercial, institutional, healthcare, transportation, and residential end markets, with repeat service needs driven by safety, compliance, and public-facing risk management.
Hospitals, medical clinics, and care homes buy disinfection services to reduce pathogen spread in high-risk environments.
Restaurants and hotels use the service to improve sanitation visibility and customer confidence.
Classrooms and similar shared spaces buy treatments to lower infection risk in dense occupancy settings.
Emergency vehicles and fleet vehicles are treated to reduce contamination in high-touch enclosed spaces.
Offices and industrial sites purchase protection for workplace hygiene and operational continuity.
Homes and professional sports teams use the service for anti-microbial protection and safety assurance.
Strategia
Management’s immediate priority is to secure financing and continue building the service business while operating as an emerging growth company. The filings emphasize a hands-on, recurring-treatment model, but the company’s near-term focus is survival and commercialization rather than expansion, given no revenue, no cash, and a going-concern warning.
The company has no cash and needs funding to sustain operations and execute its plan.
A repeat-treatment model is needed to create durable revenue and customer retention.
The company currently has no employees and relies on a sole officer, limiting scale.
Maantiede
Crona is headquartered in the United States, but the filings provided do not disclose meaningful revenue by country or region. The company’s current office is in Vancouver, British Columbia, which suggests a cross-border operating footprint, but the business remains early-stage and revenue has not yet been generated.
Riskit
Crona faces substantial going-concern and liquidity risk because it has no cash, no revenue, and recurring operating losses. Its service model also depends on customer adoption of a discretionary infection-control offering, while compliance, execution, and staffing constraints could limit growth and raise operating risk.
The company has no cash, negative working capital, and expects continued losses and negative cash flow.
Kohdistuu: All operations
Operations depend on additional equity or debt financing, which may be unavailable or expensive.
Kohdistuu: Capital structure
The service has not yet generated revenue, so customer adoption and repeat demand are unproven.
Kohdistuu: Revenue generation
The company has no employees and relies on a sole officer/director for execution.
Kohdistuu: Management and delivery
Disinfection services must comply with government rules in each facility and jurisdiction served.
Kohdistuu: Service delivery
Kirjanpito
Harkinnanvaraiset erätAuditor and management disclosures indicate substantial doubt about continuity, which affects valuation and disclosure.
Vaikutus: May require heightened scrutiny of asset recoverability and financing assumptions
A large debt forgiveness amount drove reported profit in 2025 and can create non-operating earnings volatility.
Vaikutus: Can materially inflate net income without improving core business performance
Advances from related parties are a key source of funding and affect liquidity presentation.
Vaikutus: Important for understanding sustainability of cash resources
Non-cash compensation is meaningful relative to the company’s small expense base.
Vaikutus: Affects operating expense and net loss comparability
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Zone Frontier Inc.
ZONE · Specialty Cleaning, Polishing and Sanitation Preparations
Ecolab Inc
ECL · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Ecolab makes water treatment, cleaning, sanitizing, and infection-prevention solutions used by industrial, food, healthcare, hospitality, and life sciences customers.
Concentra Group Holdings Parent, Inc.
CON · Services-Specialty Outpatient Facilities, NEC
Sotera Health Co
SHC · Services-Misc Health & Allied Services, NEC
Sotera Health is a U.S.-based provider of sterilization, laboratory testing, and advisory services for healthcare and life-science supply chains.
Sonoma Pharmaceuticals, Inc.
SNOA · Surgical & Medical Instruments & Apparatus
Sonoma Pharmaceuticals develops and sells stabilized hypochlorous acid (HOCl) products used in wound care, eye care, oral care, dermatology, podiatry, animal health care, and surface disinfection.
Mag Magna Corp
MGNC · Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Mag Magna Corp is a small U.S.-incorporated consulting and software subscription company focused on poultry farming.
Päivitetty: 28.4.2026